Cost EffectivenessGenetic TestingBreast CancerBackground: Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer.Koldehoff, AndreasUniv Hosp Cologne AoRDanner, MarionFac MedCivello, DanieleRhiem, KerstinStock, StephanieMueller, Dirk...
First, an expert reviews the family medical history to evaluate what sort of pattern of genetic breast cancer may be occurring. Next, the family member'stumorsample, if available, undergoes testing. It is impossible to run tests to analyze every single gene in a woman. Therefore, the nature ...
A cost-effectiveness analysis of multigene testing for all patients with breast cancer. JAMA Oncol. 2019;5(12):1718-1730. doi:10.1001/jamaoncol.2019.3323ArticleCrossref 27. Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ...
Further research to decrease the frequency of inconclusive results could improve the cost-effectiveness of this test. 展开 关键词: BRCA breast cancer cost-effectiveness genetic testing DOI: 10.1111/j.1524-4733.2008.00418.x 被引量: 52 年份: 2009 ...
Two separate dependent variables were used as measures for intention to obtain BRCA testing: (1) "I plan to have a genetic test for breast cancer only if my insurance covers the cost"; and (2) "I plan to have a genetic test for breast cancer, even if I have to pay for it myself...
Cancer prognostic tests such as Oncotype DX and MammaPrint appear to lower the cost of breast cancer care in the US. Such tests provide a score based on her tumor's molecular makeup that indicates when a woman can forgo expensive chemotherapy. Credit: Genomic Health ...
To examine the relative cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer provided by Genetic Services of Western Australia. The relative cost-effectiveness was assessed using a decision analytic model. The cost and outcomes of genetic testing was compared in first-...
To evaluate the cost-effectiveness of BRCA testing in women with breast cancer, and cascade testing in family members of BRCA mutation carriers. A cost-effectiveness analysis was conducted using a cohort Markov model from a health-payer perspective. The
Targeted genetic testing is a tool to identify women at increased risk of gynaecological cancer.Objective: This systematic review evaluates the results and quality of cost-effectiveness modeling studies that assessedtargeted genetic-based screen-and-treat strategies to prevent breast and ovarian cancer.Met...
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.